The stem bark extracts of Cenostigma macrophyllum attenuates tactile allodynia in streptozotocin-induced diabetic rats

Pharmaceutical Biology

Volumn 51, Issue 10, 2013, Pages 1243-1248

  Piaulino, Celyane Alves ^a   Carvalho, Fernanda Cerqueira Barroso ^a   Almeida, Buana Carvalho ^a   Chaves, Mariana Helena ^a   Almeida, Fernanda Regina Castro ^a   Brito, Salete Maria Rocha Cipriano ^a  

^a FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

Author keywords

Antinociceptive effect; Diabetes mellitus; L arginine; Mechanical nociceptive threshold; Morphine; Naloxone

Indexed keywords

ACETIC ACID ETHYL ESTER; ALCOHOL; ANTINOCICEPTIVE AGENT; BERGENIN; CENOSTIGMA MACROPHYLLUM EXTRACT; GALLIC ACID; GLUCOSE; INSULIN; LUPEOL; MORPHINE; NALOXONE; NITRIC OXIDE SYNTHASE; OPIATE RECEPTOR; PLANT EXTRACT; UNCLASSIFIED DRUG;

ACUTE DRUG ADMINISTRATION; ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BARK; CENOSTIGMA MACROPHYLLUM; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; LEGUME; MALE; NONHUMAN; PAIN THRESHOLD; PHYTOCHEMISTRY; PLANT STEM; RAT; STREPTOZOCIN DIABETES; TACTILE ALLODYNIA;

ACETATES; ANALGESICS; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; ETHANOL; FABACEAE; HYPERALGESIA; MALE; NALOXONE; NARCOTIC ANTAGONISTS; NITRERGIC NEURONS; OPIOID PEPTIDES; PAIN THRESHOLD; PHYTOTHERAPY; PLANT BARK; PLANT EXTRACTS; PLANT STEMS; PLANTS, MEDICINAL; RATS; RATS, WISTAR; RECEPTORS, OPIOID; SOLVENTS; TIME FACTORS;

EID: 84883217600     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2013.786096     Document Type: Article

References (50)

1. Ahlgren SC, Levine JD. (1993). Mechanical hyperalgesia in streptozotocin- induced diabetic rats. Neuroscience 52: 1049-55.
2. Akunne HC, Soliman KFA. (1987). The role of opioid receptors in diabetes and hyperglycemia-induced changes in pain threshold in the rat. Psychopharmacology 93: 167-72.
3. Alves CQ, David JM, David JP, et al. (2012). Flavonoids and other bioactive phenolics isolated from Cenostigma macrophyllum (Leguminosae). Quim Nova 35: 1137-40.
4. American Diabetes Association. (2002). Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 25:S5-20.
5. Apfel SC. (2006). Diabetic neuropathy models: Are they relevant? Drug Discov Today: Dis Models 3: 397-402.
6. Bian D, Nichols ML, Ossipov MH, et al. (1995). Characterization of the antiallodynic efficacy of morphine in a model of neuropathic pain in rats. Neuroreport 6: 1981-4.
7. Budai D. (2000). Neurotransmitters and receptors in the dorsal horn of the spinal cord. Acta Biol Szeged 44: 21-38.
8. Carvalho FCB. (2009). Avaliação dos efeitos de Cenostigma macrophyllum na neuropatia diabetica [unpublished master's thesis]. Available from: http://www.dominiopublico.gov.br/pesquisa/DetalheObraForm.do?select- action=&co-obra=159871 [last accessed 14 May 2012].
9. Cellek S, Qu W, Schmidt AM, Moncada S. (2004). Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: A new insight into selective nitrergic neuropathy in diabetes. Diabetologia 47: 331-9.
10. Chaplan SR, Bach FH, Pogrel JW, et al. (1994). Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Method 53: 55-63.
11. Chen SR, Sweigart KL, Lakoski JM, Pan HL. (2002). Functional mu opioid receptors are reduced in the spinal cord dorsal horn of diabetic rats. Anesthesiology 97: 1602-8.
12. Chen SR, Pan HL. (2002). Hypersensitivity of spinothalamic tract neurons associated with diabetic neuropathic pain in rats. J Neurophysiol 87: 2726-33.
13. Chen SR, Pan HL. (2003). Antinociceptive effect of morphine, but not mu opioid receptor number, is attenuated in the spinal cord of diabetic rats. Anesthesiology 99: 1409-14.
14. Cherksey BD, Altszuler N. (1974). On the mechanism of potentiation by morphine of thiopental sleeping time. Pharmacology 12: 362-71.
15. Courteix C, Eschalier A, Lavarenne J. (1993). Streptozotocin-induced diabetic rats: Behavioural evidence for a model of chronic pain. Pain 53: 81-8.
16. Desmeules JA, Kayser V, Guilbaud G. (1993). Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic pain. Pain 53: 277-85.
17. Dewan S, Sangraula H, Kumar VL. (2000). Preliminary studies on the analgesic activity of latex of Calotropris procera. J Ethnopharmacol 73: 307-11.
18. Dobretsov M, Hastings SL, Romanovsky D, et al. (2003). Mechanical hyperalgesia in rats models of systemic and local hyperglycemia. Brain Res 960: 174-83.
19. Dobretsov M, Romanovsky D, Stimers Jr. (2007). Early diabetic neuropathy: Triggers and mechanisms. World J Gastroenterol 13: 175-91.
20. Fox A, Eastwood C, Gentry C, et al. (1999). Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat. Pain 81: 307-16.
21. Freire FMT. (1994). Revisão taxonômica do gênero Cenostigma TUL (Leguminosae - Caesalpinioideae) para o Brasil [Unpublished Master's thesis]. Available from: http://www.scielo.br/pdf/abb/v10n2/v10n2a15. pdf [last accessed 14 May 2012].
22. Haley JE, Dickenson AH, Schachter M. (1992). Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in rat. Neuropharmacology 31: 251-8.
23. Kamei J, Suzuki T, Misawa M, et al. (1995). Antinociceptive effect of dihydroethorphine in diabetic mice. Eur J Pharmacol 275: 109-13.
24. Lapolla A, Traldi P, Fedele D. (2005). Importance of measuring products of non-enzymatic glycation of proteins. Clin Biochem 38: 103-15.
25. Levy D, Zochodne DW. (2004). No pain: Potential roles of nitric oxide in neuropathic pain. Pain Pract 4: 11-18.
26. Lorenzi H. (1998). Leguminosae-Caesalpinioideae, Arvores Brasileiras: Manual de Identificação e Cultivo de Plantas Arbóreas Nativas do Brasil 2: 143-44. Nova Od essa, Brazil: Editora Plantarum.
27. Lynch JJ, Michael FJ, Kowaluk EA. (1999). An adenosine kinase inhibitor attenuates tactile allodynia in a rat model of diabetic neuropathic pain. Eur J Pharmacol 364: 141-6.
28. Mao J, Price DD, Mayer DJ. (1995). Experimental mononeuropathy reduces the antinociceptive effects of morphine: Implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 61: 353-64.
29. Meller ST, Gebhart GF. (1993). Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52: 127-36.
30. Nikura K, Narita M, Butelman ER, et al. (2010). Neuropathic and chronic pain stimuli downregulate central mu-opioid and dopaminergic transmission. Trends Pharmacol Sci 31: 299-305.
31. Pepato MT, Folgado VB, Kettelhut IC, Brunetti IL. (2001). Lack of antidiabetic effect of a Eugenia jambolana leaf decoction on rat streptozotocin diabetes. Braz J Med Bio Res 34: 389-95.
32. Pietrovski EF, Rosa KA, Facundo VA, et al. (2006). Antinociceptive properties of the ethanolic extract and of the triterpene 3b,6b, 16btrihidroxilup- 20(29)-ene obtained from the flowers of Combretum leprosum in mice. Pharmacol Biochem Behav 83: 90-9.
33. Rees DA, Alcolado JC. (2005). Animal models of diabetes mellitus. Diabet Med 22: 359-70.
34. Rodríguez-Muñoz M, Sánchez-Blazquez P, Vicente-Sánchez A, et al. (2012). The mu-opioid receptor and the NMDA receptor associate in PAG neurons: Implications in pain control. Neuropsychopharmacology 37: 338-49.
35. Sasaki T, Yasuda H, Maeda K, Kikkawa R. (1998). Hyperalgesia and decreased neuronal nitric oxide synthase in diabetic rats. Neuroreport 9: 243-7.
36. Shangguan Y, Hall KE, Neubig RR, Wiley JW. (2003). Diabetic neuropathy: Inhibitory G protein dysfunction involves PKC-dependent phosphorylation of Goa. J Neurochem 86: 1006-14.
37. Silva HR, Silva CCM, Caland Neto LB, et al. (2007). Chemical constituents from bark of Cenostigma macrophyllum: Cholesterol occurrence. Quim Nova 30: 1877-81.
38. Singh B, Xu Y, McLaughlin T, et al. (2012). Resistance to trophic neurite outgrowth of sensory neurons exposed to insulin. J Neurochem 121: 263-76.
39. Snyder SH. (1992). Nitric oxide: First in a new class of neurotransmitters. Science 257: 494-6.
40. Sousa CMM, Silva HR, Vieira-Jr GM, et al. (2007). Total phenolics and antioxidant activity of five medicinal plants. Quim Nova 30: 351-5.
41. Sugimoto K, Murakawa Y, Sima AA. (2000). Diabetic neuropathy - A continuing enigma. Diabetes Metab Res Rev 16: 408-33.
42. Sugimoto K, Murakawa Y, Sima AA. (2002). Expression and localization of insulin receptor in rat dorsal root ganglion and spinal cord. J Peripher Nerv Syst 7: 44-53.
43. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. (2002). Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 25:S5-20.
44. Ueda H. (2006). Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms. Pharmacol Ther 109: 57-77.
45. UK Prospective Diabetes Study (UKPDS) Group. (1998). Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-53.
46. Warwick C, Lewis GP. (2009). A revision of Cenostigma (Leguminosae- Caesalpinioideae-Caesalpinieae), a genus endemic to Brazil. Kew Bull 64: 135-46.
47. Yaksh TL, Rudy TA. (1977). Studies on the direct spinal action of the narcotics in the production of analgesia in the rat. J Pharmacol Exp Ther 202: 411-28.
48. Zhang JM, Song XJ, Lamotte RH. (1999). Enhanced excitability of sensory neurons in rats with cutaneous hyperalgesia produced by chronic compression of the dorsal root ganglion. J Neurophysiol 82: 3359-66.
49. Zimmermann M. (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-10.
50. Zochodne DW, Levy D. (2005). Nitric oxide in damage, disease and repair of the peripheral nervous system. Cell Mol Biol 5: 255-67.